As a member of the Plasma Users Coalition (PUC) in the U.S., the National Hemophilia Foundation (NHF) has responded to a call for support of The Dublin Consensus Statement on Vital Issues Relating to the Collection of Blood and Plasma and the Manufacture of Plasma Products.
AABB News recently reported on updates made to the U.S. Food and Drug Administration’s (FDA) variant Creutzfeldt-Jakob disease (vCJD) Assessment Model. vCJD is the human form of “mad cow disease” (bovine spongiform encephalopathy, BSE).
The Centers for Disease Control and Prevention (CDC) has launched the first national surveillance system to monitor adverse events in patients who receive blood transfusions. The agency is encouraging healthcare facilities across the country to enroll in the new system, which was designed to improve patient safety.